Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer's disease.
Recent Pat CNS Drug Discov. 2010 Jun;5(2):109-17.
Please login to recommend the paper.
No Available Comments
To make a comment you must login or register.